TARGHER, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 30.814
EU - Europa 25.802
AS - Asia 21.113
SA - Sud America 3.716
Continente sconosciuto - Info sul continente non disponibili 947
AF - Africa 707
OC - Oceania 54
Totale 83.153
Nazione #
US - Stati Uniti d'America 30.209
RU - Federazione Russa 9.054
SG - Singapore 8.931
GB - Regno Unito 7.106
CN - Cina 5.181
BR - Brasile 2.955
IT - Italia 2.355
HK - Hong Kong 2.330
VN - Vietnam 1.875
FR - Francia 1.553
IE - Irlanda 1.296
DE - Germania 1.227
SE - Svezia 997
FI - Finlandia 952
KR - Corea 767
BD - Bangladesh 392
UA - Ucraina 391
IN - India 288
AR - Argentina 280
CA - Canada 261
ID - Indonesia 253
NL - Olanda 246
MX - Messico 175
NG - Nigeria 163
JP - Giappone 155
EC - Ecuador 144
TR - Turchia 138
IQ - Iraq 119
ZA - Sudafrica 116
CO - Colombia 105
ES - Italia 105
PK - Pakistan 92
PL - Polonia 86
AT - Austria 78
BJ - Benin 78
TG - Togo 73
BE - Belgio 60
IR - Iran 56
SA - Arabia Saudita 55
VE - Venezuela 53
UZ - Uzbekistan 52
EG - Egitto 49
PE - Perù 48
AU - Australia 45
PH - Filippine 45
PY - Paraguay 45
CL - Cile 43
MY - Malesia 43
MA - Marocco 42
TN - Tunisia 42
IL - Israele 39
KE - Kenya 38
AZ - Azerbaigian 36
JM - Giamaica 32
JO - Giordania 32
LT - Lituania 29
TW - Taiwan 29
DZ - Algeria 28
AE - Emirati Arabi Uniti 25
CR - Costa Rica 24
GR - Grecia 24
UY - Uruguay 23
DK - Danimarca 22
AL - Albania 21
TH - Thailandia 21
NP - Nepal 19
RO - Romania 19
HN - Honduras 18
KZ - Kazakistan 18
CH - Svizzera 17
BO - Bolivia 16
CZ - Repubblica Ceca 16
EU - Europa 16
GT - Guatemala 16
HU - Ungheria 16
LU - Lussemburgo 16
DO - Repubblica Dominicana 15
ET - Etiopia 14
KH - Cambogia 14
PS - Palestinian Territory 14
XK - ???statistics.table.value.countryCode.XK??? 14
MD - Moldavia 12
BG - Bulgaria 11
OM - Oman 11
BH - Bahrain 10
KG - Kirghizistan 10
LV - Lettonia 10
NO - Norvegia 10
PT - Portogallo 10
SN - Senegal 10
TT - Trinidad e Tobago 10
LB - Libano 9
RS - Serbia 9
BY - Bielorussia 8
HR - Croazia 8
MK - Macedonia 8
PR - Porto Rico 8
BB - Barbados 7
BS - Bahamas 7
CY - Cipro 7
Totale 82.060
Città #
Southend 6.313
Singapore 4.552
Ashburn 3.545
Dallas 2.836
Jacksonville 2.803
San Jose 2.736
Moscow 2.681
Hong Kong 2.294
Chandler 2.278
Woodbridge 1.759
Council Bluffs 1.421
Ann Arbor 1.275
Dublin 1.266
The Dalles 1.108
Verona 1.093
Houston 1.000
Beijing 797
Ho Chi Minh City 654
Lawrence 571
Princeton 571
Wilmington 513
Los Angeles 497
Hanoi 420
New York 405
Nanjing 347
Jinan 334
Buffalo 319
Santa Clara 296
São Paulo 265
Helsinki 262
Redondo Beach 244
Shenyang 244
Columbus 218
Sindelfingen 209
Hebei 168
Tianjin 168
Milan 167
London 156
Munich 146
Abuja 144
Guangzhou 131
Redmond 126
Tokyo 125
Changsha 119
Orem 119
Rio de Janeiro 110
Seattle 108
Oude Meer 106
Nanchang 105
Jakarta 101
Seoul 101
Chicago 97
Hangzhou 97
Jiaxing 96
Zhengzhou 96
Phoenix 93
Haikou 92
Ningbo 92
Montreal 87
Frankfurt am Main 85
Rome 83
Dong Ket 81
Brooklyn 80
Lancaster 80
Norwalk 79
Turku 79
Cotonou 78
Taizhou 77
Shanghai 76
Belo Horizonte 75
Lomé 73
Haiphong 71
Redwood City 70
Taiyuan 70
Washington 69
Boardman 67
Chennai 67
Fairfield 67
Nuremberg 65
Warsaw 64
Johannesburg 61
Atlanta 60
Mexico City 60
Da Nang 59
Brussels 57
Denver 57
Toronto 57
Amsterdam 56
San Francisco 53
Quito 51
Baghdad 49
Brasília 48
Bologna 47
Meda 47
Stockholm 47
Dongguan 46
Tashkent 46
Guayaquil 45
Poplar 45
Lahore 43
Totale 51.666
Nome #
Mitral Regurgitation and Increased Risk of All-Cause and Cardiovascular Mortality in Patients with Type 2 Diabetes 650
Risk of type 2 diabetes in patients with non-alcoholic fatty liver disease: Causal association or epiphenomenon? 621
Mortality from chronic liver diseases in diabetes 605
Severe hypoglycemia in patients with known diabetes requiring emergency department care: a report from an Italian multicenter study. 395
Glucagon-Like Peptide-1 Receptor Agonists Improve MASH and Liver Fibrosis: A Meta-Analysis of Randomised Controlled Trials 336
Abnormal liver enzymes in children and infants with COVID-19: A narrative review of case-series studies 325
STEATOEPATITE NON ALCOLICA E FIBROSI EPATICA IN UNA CASISTICA DI PAZIENTI OBESI SOTTOPOSTI A CHIRURGIA BARIATRICA 306
A laboratory standpoint on the role of hemoglobin A1c for the diagnosis of diabetes in childhood: more doubts than certainties? [Review] 274
Does high LDL-cholesterol cause cardiovascular disease? 270
Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease. 265
Biomarker Discovery for Metabolic Dysfunction-associated Steatotic Liver Disease Utilizing Mendelian Randomization, Machine Learning, and External Validation 263
Long-Acting GLP-1 Receptor Agonist Exenatide Influence on the Autonomic Cardiac Sympatho-Vagal Balance 254
Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with NAFLD (The RAED2 randomized trial). 252
Glycated haemoglobin is inversely related to serum vitamin d levels in type 2 diabetic patients. 238
Aortic and mitral annular calcification are predictive of all-cause and cardiovascular mortality in patients with type 2 diabetes. 234
Abnormal serum alanine aminotransferase levels are associated with impaired insulin sensitivity in young women with polycystic ovary syndrome. 225
ABO blood group, hypercoagulability, cardiovascular and cancer risk. [Review] 225
Response to Comment on Mantovani et al. Sodium-Glucose Cotransporter 2 Inhibitor Use and Risk of Liver-Related Events in Patients With Type 2 Diabetes: A Meta-analysis of Observational Cohort Studies. Diabetes Care 2025;48:1042-1052 215
A Perspective on Metabolic Syndrome and Nonalcoholic Fatty Liver Disease. 214
Nonalcoholic Fatty Liver Disease Is Independently Associated With an Increased Incidence of Chronic Kidney Disease in Patients With Type 1 Diabetes. 212
Hyperuricaemia: relationships to body fat distribution and other components of the insulin resistance syndrome in 38-year-old healthy men and women 211
Association between subclinical left ventricular systolic dysfunction and glycemic control in asymptomatic type 2 diabetic patients with preserved left ventricular function 211
Increased aortic stiffness index in patients with type 1 diabetes without cardiovascular disease compared to controls 209
American Diabetes Association - 75th Scientific Meeting; Section: Epidemiology/Genetics; Poster n. 1581-P: "Nonalcoholic Fatty Liver Disease Is Associated with Heart Valve Calcification in Type 2 Diabetes" 208
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 208
Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes. 207
A fatty liver leads to decreased kidney function? 207
Glucagon-like peptide-1 receptor agonists for treatment of nonalcoholic steatohepatitis: new insights from subcutaneous semaglutide 207
Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes. 203
Association between decreasing estimated glomerular filtration rate and risk of cardiac conduction defects in patients with type 2 diabetes 202
Nonalcoholic fatty liver disease is associated with an increased prevalence of distal symmetric polyneuropathy in adult patients with type 1 diabetes 201
NAFLD, diabete tipo 2, malattia cardiovascolare? 200
Nonalcoholic fatty liver disease is associated with aortic valve sclerosis in patients with type 2 diabetes mellitus. 197
Lower levels of 25-hydroxyvitamin D3 are associated with a higher prevalence of microvascular complications in patients with type 2 diabetes. 197
A novel quantitative ultrasound technique for identifying non-alcoholic steatohepatitis 196
Association between non-alcoholic fatty liver disease and decreased lung function in adults: a systematic review and meta-analysis 195
Prevalence of Cardiovascular Autonomic Neuropathy in a Cohort of Patients With Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 194
Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes 193
"Not all forms of NAFLD were created equal". Do metabolic syndrome-related NAFLD and PNPLA3-related NAFLD exert a variable impact on the risk of early carotid atherosclerosis? 193
Non-alcoholic fatty liver disease and increased risk of all-cause mortality in elderly patients admitted for acute heart failure 193
25-hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. 192
Association between serum TSH, free T4 and serum liver enzyme activities in a large cohort of unselected outpatients. 191
Association between lower plasma adiponectin levels and higher plasma thrombin generation parameters in men with type 2 diabetes: role of plasma triglycerides 190
The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments 190
Nonalcoholic Fatty Liver Disease Is Associated With Ventricular Arrhythmias in Patients With Type 2 Diabetes Referred for Clinically Indicated 24-Hour Holter Monitoring 189
Acquired factor VIII inhibitors in oncohematology: a systematic review. 187
Liver steatosis and its relation to plasma haemostatic factors in apparently healthy males. Role of the metabolic syndrome. 186
Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes. 186
Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescents 186
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement 186
25-hydroxyvitamin D deficiency and inflammation and their association with hemoglobin levels in chronic kidney disease. 185
Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function 185
Comparison of two creatinine-based estimating equations in predicting all-cause and cardiovascular mortality in patients with type 2 diabetes. 185
Prevalence of neuropathy in type 2 diabetic patients and its association with other diabetes complications: The Verona Diabetic Foot Screening Program. 185
Relationship of fasting insulin to cardiovascular risk factor is already present in young men. The Verona Young Men Atherosclerosis Risk Factor Study. 184
Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes 183
Hyperuricemia is associated with an increased prevalence of paroxysmal atrial fibrillation in patients with type 2 diabetes referred for clinically indicated 24-h Holter monitoring 183
Hyperuricemia is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes 181
Hemostatic and fibrinolytic abnormalities in endocrine diseases: a narrative review. [Review] 181
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 180
Association Between Diabetes and 1-Year Adverse Clinical Outcomes in a Multinational Cohort of Ambulatory Patients With Chronic Heart Failure: Results From the ESC-HFA Heart Failure Long-Term Registry 179
Anaemia, independent of chronic kidney disease, predicts all-cause and cardiovascular mortality in type 2 diabetic patients. 179
Relation of serum gamma-glutamyltransferase to atherogenic dyslipidemia and glycemic control in type 2 diabetes. 178
Relationship between increased left atrial volume and microvascular complications in patients with type 2 diabetes 178
Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus 178
Association between MBOAT7 rs641738 polymorphism and non-alcoholic fatty liver in overweight or obese children 178
Moderate alcohol consumption and its relation to visceral fat and plasma androgens in healthy women 177
Increased aortic pulse wave velocity as measured by echocardiography is strongly associated with poor prognosis in patients with heart failure. 177
Inter-atrial shunt inversion by the sitting position in a patient with a patent foramen ovale and acute pulmonary embolism. 177
Increased aortic stiffness in adults with chronic indeterminate Chagas disease 177
Diabetic retinopathy is associated with an increased incidence of cardiovascular events in type 2 diabetic patients. 177
Concordance between MAFLD and NAFLD diagnostic criteria in "real-world" data 176
Predictors of estimated glomerular filtration rate decline in patients with type 2 diabetes and preserved kidney function. 174
Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis 174
Association between Higher Circulating Leucine-Rich α-2 Glycoprotein 1 Concentrations and Specific Plasma Ceramides in Postmenopausal Women with Type 2 Diabetes 173
Interpatient phenotypic inconsistency in severe congenital hemophilia: a systematic review of the role of inherited thrombophilia 173
Anaphylaxis in patients with congenital bleeding disorders and inhibitors. [Review] 173
Psychological distress, Self-Efficacy and Glycemic Control in Type 2 Diabetes 173
Association between PNPLA3rs738409 polymorphism decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease 172
Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: An updated meta-analysis 172
Nonalcoholic Fatty Liver Disease and Estimated Insulin Resistance in Obese Youth: A Mendelian Randomization Analysis 172
Elevated serum uric acid concentrations independently predict cardiovascular mortality in type 2 diabetic patients. 171
Increased prevalence of chronic kidney disease in patients with type 1 diabetes and non-alcoholic fatty liver. 171
Adiponectin and migraine: systematic review of clinical evidence. 169
Intimal-medial thickness of the carotid artery in nondiabetic and non-insulin-dependent diabetic subjects. Relationship with insulin resistance. 168
Relationship between early diastolic dysfunction and abnormal microvolt T-wave alternans in patients with type 2 diabetes. 168
Relationships of blood pressure to fibrinolysis: influence of anthropometry, metabolic profile and behavioural variables. 167
Nonalcoholic Fatty Liver Disease Is Associated With Higher 1-year All-Cause Rehospitalization Rates in Patients Admitted for Acute Heart Failure 167
Association between nonalcoholic fatty liver disease and colorectal Tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis 167
Usefulness of Subclinical Left Ventricular Midwall Dysfunction to Predict Cardiovascular Mortality in Patients With Type 2 Diabetes Mellitus. 166
Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure 166
Association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease: an updated meta-analysis 162
Association of Plasma Ceramides With Myocardial Perfusion in Patients With Coronary Artery Disease Undergoing Stress Myocardial Perfusion Scintigraphy 162
Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis 162
Genetic and biochemical heterogeneity of cardiac troponins: clinical and laboratory implications. [Review] 161
Echocardiographically Derived Pulse Wave Velocity and Diastolic Dysfunction Are Associated with an Increased Incidence of Atrial Fibrillation in Patients with Systolic Heart Failure 161
Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker 161
Black esophagus syndrome associated with diabetic ketoacidosis 160
Evidence of left atrial remodeling and left ventricular diastolic dysfunction in type 2 diabetes mellitus with preserved systolic function 160
Association between increased plasma ceramides and chronic kidney disease in patients with and without ischemic heart disease 160
Totale 20.942
Categoria #
all - tutte 307.152
article - articoli 303.033
book - libri 0
conference - conferenze 652
curatela - curatele 0
other - altro 873
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.594
Totale 614.304


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.462 0 0 97 149 119 195 47 286 164 127 333 945
2022/20237.426 693 528 852 1.226 703 1.803 85 405 758 51 207 115
2023/20244.105 174 392 422 471 499 588 243 268 50 170 556 272
2024/202512.357 749 786 414 1.974 692 345 536 655 1.907 991 911 2.397
2025/202635.723 2.796 2.363 3.352 5.511 7.743 2.187 3.267 2.212 2.739 1.713 636 1.204
2026/20271.917 649 1.258 10 0 0 0 0 0 0 0 0 0
Totale 83.153